Program Goals

Overview

Glatiramer Acetate 3 Times a Week

Glatiramer Acetate 3 Times a Week (cont)

Glatiramer Acetate 3 Times a Week (cont): Safety

Glatiramer Acetate: Generic Formulation

Pegylated Interferon for MS

Pegylated Interferon (cont): Pharmacokinetics

Pegylated Interferon (cont): ADVANCE Phase 3 Study

Clinical Impact of New Injectable Formulations

Oral Therapies for MS

Oral Therapies: Mechanisms

Oral Therapies: Efficacy

Oral Therapies: Safety

Oral vs Standard Therapies

Considerations in Selecting Oral Therapy

Switching to an Oral Agent: Counseling Considerations

Switching to an Oral Agent: Is a Washout Period Necessary?

Looking Ahead

Looking Ahead (cont)

Summary and Key Points

Abbreviations

References

References (cont)